Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Assessing response to anti-CD20 therapy by genotyping C1q components

Assessing response to anti-CD20 therapy by genotyping C1q components

US Patent 7723036 · Granted May 25, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for tumor immunotherapy2025
Identification of T-cell trafficking genes and uses thereof for increasing infil2025
Nucleic acid aptamers2021
Methods for treating tumors in situ including intratumor injection of cytotoxic 2019
Parasitic biological agents for treatment and prevention of graft versus host di2017
Biodegradable particulate formulations2017
Methods for enhancing antibody-induced cell lysis and treating cancer2009
Humanized antibodies against CD32008
Methods and reagents for the rapid and efficient isolation of circulating cancer2008
Methods and reagents for the rapid and efficient isolation of circulating cancer2003
Prostate cell surface antigen-specific antibodies2003
Methods and reagents for the rapid and efficient isolation of circulating cancer2002